ST Pharm, a leading technology-driven RNA CDMO based in South Korea, and Belgium-based Quantoom Biosciences, a specialis...
A team of Korean researchers has made a breakthrough that will greatly enhance the efficiency of respiratory disease res...
Minister Cho KyooHong of the Ministry of Health and Welfare (MoHW), Korea attended the 2nd Korea-ASEAN Health Ministers ...
Minister Cho KyooHong of the Ministry of Health and Welfare of Republic of Korea visited Singapore recently to discuss a...
The Ministry of Health and Welfare, the National Cancer Center, and the Korea Health Information Service&...
South Korea-based startup AITRICS has announced the signing of a Memorandum of Understanding (MoU) with ezCare...
Korea's Ministry of Health and Welfare and the Korea Health Industry Development Institute (KHIDI) recent...
SK bioscience, a global innovative vaccine and biotech company based in South Korea, has signed a Simple Agreement for F...
Avance Clinical, a contract research organisation (CRO) for biotechs, has announced the appointment of Jessica Han as Di...
Mélanie Joly, Canada’s Minister of Foreign Affairs, visited the International Vaccine Institute’s (IV...
GC Cell Corporation and Taiwan-based Lukas Biomedical has formally signed an international strategic cooperation agreeme...
Seegene Inc., a leading South Korean company providing a total solution for PCR molecular diagnostics, demonstrated its ...
ADM Korea, a subsidiary of Hyundai Bioscience, has announced that the first clinical trial target population for its nic...
AIRS Medical, a pioneering force in artificial intelligence (AI) and robotics for healthcare applications, has announced...
Genexine, a publicly-listed, clinical-stage Korean biopharmaceutical startup has announced a merger with EPD Biotherapeu...
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, Lotte Biologics, under the leadersh...
South Korea-based International Vaccine Institute (IVI) has signed a memorandum of understanding (MoU) with the Catholic...
China-based startup Hasten Biopharmaceutical has successfully acquired the asset rights of 14 branded products across Pa...
